Navigation Links
IGERT fellows to design biodevices using flexible electronics
Date:9/17/2007

Growing interest in using flexible electronics for next-generation biomedical devices has prompted the creation of a new graduate student research program at Cornell, funded by the National Science Foundation (NSF).

Cornell's Nanobiotechnology Center (NBTC) has received $3.2 million over five years from NSF's Integrative Graduate Education and Research Traineeship (IGERT) program. Recruited IGERT fellows will work in teams to design and test biodevices -- from biologically compliant neural implants to wireless drug delivery -- using flexible electronics.

Called the FlexEBio research grant, the program will focus on: biosensors; the material-biology interface; and flexible implantable electronics for medical monitoring, diagnostics and therapeutics.

The broad research area of flexible electronics has been developing over the past decade, said Christopher Ober, the F.N. Bard Professor of Materials Engineering and principal investigator. Such efforts have to date produced flexible displays and flat-panel lighting, as well as circuitry printed onto flat, plastic substrates -- using methods similar to how an inkjet printer prints on paper.

Scientists have begun to combine potentially low-cost printing methods with biomedical applications, which is where Cornell's new IGERT fellows will do their research.

"Over the next decade, I think Cornell has the opportunity to have an enormous impact in the biomedical area of flexible electronics, and this work will spill into other areas as well," Ober said.

Over the next five years, the IGERT funding will bring a total of between 30 and 40 fellows to Cornell, as well as to program partners SUNY Binghamton and the University of Albany/Wadsworth Center. Each IGERT fellow will work on team research projects, which will be based at one of these core institutions. Existing partnerships with Lincoln University, Howard University and Clark Atlanta University will allow students at these institutions to partic
'/>"/>

Contact: Press Relations Office
pressoffice@cornell.edu
607-255-6074
Cornell University News Service
Source:Eurekalert

Page: 1 2

Related biology news :

1. Newly discovered pathway might help in design of cancer drugs
2. Medical molecules designed to respond to visible light that can penetrate tissue
3. OneWorld Health drug receives Orphan designation from U.S. and European regulatory agencies
4. Designing vaccines by computer
5. New design : complete
6. Mouse with designer liver has enhanced glucose tolerance, insulin response
7. Computational Tool Predicts How Drugs Work In Cells, Advancing Efforts To Design Better Medicines
8. Redesigned protein accelerates blood clotting
9. Two designer drugs hit same lung cancer target, but only one is effective
10. MWG Biotech expands siMAX?siRNA portfolio with new scales, lengths and design tools
11. Scientists and engineers apply natures design to human problems

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...09) Whitehead researchers have developed a new ty...pecific genes and proteins used by pathogens, acco...an cell cultures genes are present in two copies: ...her. Gene inactivation by mutation is therefore in...e second copy usually remains active and takes ove...
(Date:11/25/2009)...easy lives. In addition to mammalian immune system... called bacteriophages, viruses that kill half the...teria and another class of microorganisms called a...uch as deep-sea volcanic vents) manage just fine, ...fense system that helps protect them from many vir...
(Date:11/25/2009)...nt professors recently received funding from the N...rch beneficial to understanding the environment. T...ackwood, assistant professor in the Department of ... two separate research projects. , His first pro...ties and Functions from the Leaf to the Landscape,...
Breaking Biology News(10 mins):Knockouts in human cells point to pathogenic targets 2Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3Kent State University professors focus research on the environment with grants totaling $890,000 2Paper Highlights Antimicrobial Effectiveness of Medical Grade Honey in Topical Wound Care 52801 1Paper Highlights Antimicrobial Effectiveness of Medical Grade Honey in Topical Wound Care 52801 2Radiation Plus Chemo a Good Option in Lung Cancer 52797 1Radiation Plus Chemo a Good Option in Lung Cancer 52797 2Genetic testing may be valuable in treating colorectal cancer 52793 1Genetic testing may be valuable in treating colorectal cancer 52793 2
...WASHINGTONThe science and technology policymaking ...at the next president can better address key issue..., to national security, and the ability of the Uni...lly. The report,s primary recommendations are that...nally respected leader to be Assistant for Science...
...Washington, DC, June 13, 2008 Mary Tyler Moore, t...tional chairman, and her husband, S. Robert Levine...Clinical Research Award" to a team of Florida scie...gton, DC. , The recipients of this year,s prestig...he JDRF Gene Therapy Center for Diabetes and Diabe...
... This release is available in German . , Beca...ndling it, tetrachloromethane (carbon tetrachlorid... countries. However, the processes used in the pro... chloroform (trichloromethane, CHCl3), also produc... rid of this unwanted substance? A team headed by ...
Other Biology News:White House science office needs upgrade 2White House science office needs upgrade 3Florida researchers receive JDRF 'Excellence in Clinical Research Award' 2Fair trade 2
(Date:11/24/2009)... Sigma-Aldrich Corporatio...Q OMX conference on Tuesday, December 1st at 1:45 ...es may listen via live audio broadcast over the In...a a ldrich.com/ . Users can click the "Webcast...Aldrich: Sigma-Aldrich is a leading Life Science...
(Date:11/24/2009)... Nov. 24 NeurogesX, Inc....used on developing and commercializing novel pain ... DiTonno, President and Chief Executive Officer, i...ffray Health Care Conference, to be held December ..., New York. ,, Mr. DiTonno and Stephen Ghiglie...
(Date:11/24/2009)... endpoint has been met for patients with advanced-...QUEBEC CITY, Nov. 24 /PRNewswire-FirstCall/ - AEte..."Company"), a global biopharmaceutical company foc...unced positive efficacy data from a Phase 2 study ...S-108 (formerly AN-152), in patients with advanced...
(Date:11/24/2009)..., Nov. 24 Genomic Health... Scott, Genomic Health,s Executive Chairman, will ...re Conference in New York City on Tuesday, Decembe...ive and subsequently archived webcast of the prese...enomic Health,s website at http://investor.genomi...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2
...s Technologies, Inc. (CTi), a professional consult... Science Applications International Corporation (N...th the National Institute of Allergy and Infectiou...ealth (NIH). The contract to SAIC is for $19 mill...will provide regulatory affairs, technical and adm...
...based company has,successfully grown the first Low...gnificantly lower levels of harmful radioactive ca...hildren nourished with safer, low radiocarbon,Life...r genetic damage events,over their lifetime. By re...efects may also be reduced. Since genetic damage m...
...otech, Inc.,(Nasdaq: OSTE ), a leader in the eme...healing, announced today that its Board of Directo... which up to $5.0 million of,Osteotech,s common st...cuted,from time to time at current market prices t...ctions in such amounts as management deems appropr...
Other Biology Technology:Cascades Technologies, Inc. and SAIC Team on $19 Million Contract with National Institutes of Health 2World's First Low Radiocarbon Food May Reduce Risks of Cancer and Birth Defects, and Possibly Even Slow the Aging Process 2Osteotech Announces Stock Repurchase Program 2
Rabbit Anti-Human Q86TS7 Polyclonal Antibody, Unconjugated from Atlas Antibodies
...ontains 4 deuterium atoms at the 9, 10, 12, and 13...standard for the quantification of 9(S)-HODE by GC...y the lipoxygenation of linoleic acid in both plan...rotic plaques, as an esterified component of membr...
12(S)-HETE-d8, Deuterium Conjugated/Tagged from Cayman Chemical
Silencer Pre-designed siRNA, HPLC purified, annealed from Ambion
Biology Products: